human | Q5 |
P496 | ORCID iD | 0000-0002-3495-6268 |
P1053 | ResearcherID | S-7060-2018 |
P1153 | Scopus author ID | 55205386300 |
P106 | occupation | researcher | Q1650915 |
Q45325613 | Avasimibe: A novel hepatitis C virus inhibitor that targets the assembly of infectious viral particles |
Q27469080 | Cell-death-inducing DFFA-like Effector B Contributes to the Assembly of Hepatitis C Virus (HCV) Particles and Interacts with HCV NS5A |
Q34057855 | Endoplasmic reticulum stress links hepatitis C virus RNA replication to wild-type PGC-1α/liver-specific PGC-1α upregulation |
Q43072520 | Epithelium-Specific ETS (ESE)-1 upregulated GP73 expression in hepatocellular carcinoma cells |
Q35114636 | GP73 is upregulated by hepatitis C virus (HCV) infection and enhances HCV secretion |
Q51697097 | GP73 was upregulated in PBMC stimulated with ConA but failed to promote lymphocyte proliferation. |
Q34138049 | Golgi phosphoprotein 2 (GOLPH2/GP73/GOLM1) interacts with secretory clusterin |
Q45149028 | ORF390 of white spot syndrome virus genome is identified as a novel anti-apoptosis gene. |
Q45357508 | Rare inborn errors associated with chronic hepatitis B virus infection |
Q34091360 | The Golgi localization of GOLPH2 (GP73/GOLM1) is determined by the transmembrane and cytoplamic sequences |
Search more.